(Q40447273)

20 September 2017

1 reference

title

Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC). (English)

1 reference

20 September 2017

0 references

anti-retroviral agent

0 references

prevention of HIV/AIDS

0 references

dementia

0 references

AIDS dementia complex

1 reference

Portegies P

1

1 reference

20 September 2017

publication date

1 January 1995

1 reference

20 September 2017

1 reference

20 September 2017

volume

49 Suppl 1

1 reference

20 September 2017

page(s)

25-31; discussion 38-40

1 reference

Central nervous system dysfunction in acquired immunodeficiency syndrome

20 September 2017

cites work

1 reference

12 December 2020

Pathology of HIV-1 infection of the central nervous system. A review

1 reference

12 December 2020

The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex

1 reference

12 December 2020

Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine

1 reference

12 December 2020

CT, MR, and pathology in HIV encephalitis and meningitis

1 reference

12 December 2020

White matter disease in AIDS: findings at MR imaging

1 reference

12 December 2020

[The AIDS-dementia complex: primary infection by human immunodeficiency virus type I]

1 reference

12 December 2020

Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus

1 reference

12 December 2020

Neurologic manifestations of HIV infection

1 reference

12 December 2020

Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey

1 reference

12 December 2020

Neuropathological evidence that zidovudine reduces incidence of HIV infection of brain

1 reference

12 December 2020

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

12 December 2020

Therapy for human immunodeficiency virus infection

1 reference

12 December 2020

Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment

1 reference

12 December 2020

Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine.

1 reference

12 December 2020

AIDS dementia complex and didanosine

1 reference

12 December 2020

Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases

1 reference

12 December 2020

Neurologic manifestations of AIDS.

1 reference

12 December 2020

Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex

1 reference

12 December 2020

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology

1 reference

12 December 2020

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment

1 reference

12 December 2020

The AIDS dementia complex: I. Clinical features

1 reference

12 December 2020

Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.

1 reference

12 December 2020

Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases

1 reference

12 December 2020

Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus

1 reference

12 December 2020

The AIDS dementia complex: II. Neuropathology.

1 reference

12 December 2020

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

12 December 2020

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

12 December 2020

Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex.

1 reference

12 December 2020

Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status

1 reference

12 December 2020

Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine

1 reference

12 December 2020

The AIDS dementia complex

1 reference

12 December 2020

Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group

1 reference

12 December 2020

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study

1 reference

12 December 2020

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia

1 reference

12 December 2020

Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.

1 reference

12 December 2020

Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection.

1 reference

12 December 2020

Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV

1 reference

12 December 2020

Identifiers

1 reference